So, another earnings report comes out in a short while.. I know trading on inside knowledge is illegal.. but he would have some insight into the coming report.. why sell now? If the ER is less than expected the stock will tank

Why would the ceo not provide future guidance.. doesn’t make sense.

yes, I'm glad I was wrong.

It seems the expectations have historically been met with disappointment…here we are again, based on current SP, IMO anything under $28mil would be a disappointment.. hope I’m wrong but I don’t think it will be there

Question, you’ve been saying koolaid, sub .12 since the stock was sub .30… that’s a .40 increase.. I assume you don’t feel bad that you were wrong then and maybe persuaded some not to dip a toe in and therefore lost out on a significant upside.. hope that makes you feel good

Curious, when do you think it will drop to .12.. you seem pretty sure, wondering if you have a timeline.

The constant, news coming on Monday is like the routine outlandish earnings predictions.. all fluff to only set up disappointment.. why? So someone can say “see how good I am” … kinda strange need to stroke an ego

Wonder where this bottoms out..

Wonder where this bottom is? Doesn’t look good…

Surprised no one has mentioned this
https://www.yahoo.com/news/rfk-jr-really-away-adhd-152947023.html

I’d like to adjust this to .33

.43

https://www.cnbc.com/2025/01/30/fda-approves-vertex-non-opioid-painkiller-drug.html

Is there a gap this morning

Imo this little green is a setup.. watch them take it down again this afternoon

I may be wrong but that looks like it would be around .43..

Wonder where the bottom is

Is there an opening gap?

Hopefully some day the MM will not be able to influence the price, due to a buyout being announced.

How are all the negative follow up comments explained… satire or not it seems to be working

Congrats longs… sorry my contrarian views.. this is a huge accomplishment for the company.

What is strange, the last call the ceo said there was an issue with the supplier and the FDA ended another month to review.. but now after a month delay he’s saying there’s still an issue , which may require an amendment.. I suspect that will require multiple months to resolve..

Agree… doesn’t sound promising

This does not sound promising…
The API supply, supplier had issues with the DMF. We are not allowed to see the DMF.

We only give, FDA authorization to, look at the EMF and approve it after the vendor lets us do that. So FDA does, once the FDA looked at it and noticed some problems, they updated us and so did our supplier. They said that they have some issues with us. Our application, to the best of my knowledge, and as per FDA, did not have any issues with it. So now, all observations by the API supplier have been addressed.

We have evaluated them and they look adequate, and we believe the FDA will find them adequate as well. If the FDA does, then approval come in next week. If it doesn't, there is nothing that I've seen that looks like it's major. It will be a minor amendment that we will work with FDA

There seems to be a theme that the a FDA approval for Vyvanse is a given.. it could be more disappointment like the recent rev estimates..

Probably see .30s today

Well there it is, way off from all high expectations.. as mentioned, I would expect a significant drop tomorrow.

Wow.. given today, this could go into the .20s after earnings and CC..

Sell off starting a day early.. could be ugly tomorrow

IMO, This will sell off on Friday after disappointing earnings ..

Bs

Thanks, proves my point.. can't provide a logical answer.. so just ignore it.

Why bother? its all about the perception of a self-serving CEO of a private company doing business with his publicly held company... give me one example, just one, where this type of arrangement is precedented.. why not disclose to provide full transparency. Why not just disclose it? pretty simple.. the lack of full disclosure just adds to speculation he is self-serving.

ha, good response... so that the best you can do for why not to disclose it? Give me a break.

Simple question.. does it make sense for the Mikah/Nasrat to disclose how much he paid for the 1/2? Full transparency on his cost in relation to selling it back would dispel appearance of a self-serving deal.

At the risk of being labeled a yes man… this post is absolutely right on.

There is no doubt this is a conflict of interest.. Mikah being involved by providing research, development, sales and licensing is an absolute joke.

watch out below...

IMO Unfortunately, this will be back in single digits by end of week..

I agree, why would there be so much available for sale at these levels.. something doesn’t seem right IMO